528 related articles for article (PubMed ID: 17612561)
1. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
[TBL] [Abstract][Full Text] [Related]
2. Short-term alanyl-glutamine dipeptide pretreatment in liver ischemia-reperfusion model: effects on microcirculation and antioxidant status in rats.
Szijártó A; Hahn O; Batmunkh E; Stangl R; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Gero D; Szabó C; Kupcsulik P; Harsányi L
Clin Nutr; 2007 Oct; 26(5):640-8. PubMed ID: 17689840
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine could not improve hepatic warm ischemia-reperfusion injury despite ameliorated blood flow.
Yonezawa K; Tolba RH; Wetter A; Yamamoto Y; Yamaoka Y; Minor T
J Surg Res; 2005 May; 125(1):16-22. PubMed ID: 15836845
[TBL] [Abstract][Full Text] [Related]
4. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
[TBL] [Abstract][Full Text] [Related]
5. Propofol attenuates the decrease of dynamic compliance and water content in the lung by decreasing oxidative radicals released from the reperfused liver.
Chan KC; Lin CJ; Lee PH; Chen CF; Lai YL; Sun WZ; Cheng YJ
Anesth Analg; 2008 Oct; 107(4):1284-9. PubMed ID: 18806041
[TBL] [Abstract][Full Text] [Related]
6. [Methods of increasing ischemic tolerance in liver surgery].
Szijártó A
Magy Seb; 2008 Jun; 61(3):128-35. PubMed ID: 18515218
[TBL] [Abstract][Full Text] [Related]
7. GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats.
Li JY; Gu X; Zhang WH; Jia S; Zhou Y
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):518-23. PubMed ID: 19822496
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.
Khandoga A; Biberthaler P; Enders G; Krombach F
Crit Care Med; 2004 Feb; 32(2):472-7. PubMed ID: 14758166
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus mediated gene transfer of antiapoptotic protein in hepatic ischemia-reperfusion injury: the paradoxical effect of Bcl-2 expression in the reperfused liver.
Oshiro T; Shiraishi M; Muto Y
J Surg Res; 2002 Mar; 103(1):30-6. PubMed ID: 11855914
[TBL] [Abstract][Full Text] [Related]
10. Reduction of liver ischemia-reperfusion injury via glutamine pretreatment.
Stangl R; Szijártó A; Ónody P; Tamás J; Tátrai M; Hegedus V; Blázovics A; Lotz G; Kiss A; Módis K; Gero D; Szabó C; Kupcsulik P; Harsányi L
J Surg Res; 2011 Mar; 166(1):95-103. PubMed ID: 20080263
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
[TBL] [Abstract][Full Text] [Related]
12. Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70.
Bedirli A; Sakrak O; Muhtaroglu S; Soyuer I; Guler I; Riza Erdogan A; Sozuer EM
J Surg Res; 2004 Nov; 122(1):96-102. PubMed ID: 15522321
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression.
Giakoustidis DE; Giakoustidis AE; Iliadis S; Koliakou K; Antoniadis N; Kontos N; Papanikolaou V; Papageorgiou G; Kaldrimidou E; Takoudas D
J Surg Res; 2010 Apr; 159(2):720-8. PubMed ID: 19394642
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
Gong J; Lao XJ; Zhang SJ; Chen S
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with calcitonin gene-related peptide attenuates hepatic ischemia/reperfusion injury in rats.
Song SW; Guo KJ; Shi R; Cheng Y; Liu YF
Transplant Proc; 2009 Jun; 41(5):1493-8. PubMed ID: 19545664
[TBL] [Abstract][Full Text] [Related]
17. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.
Mota-Filipe H; Sepodes B; McDonald MC; Cuzzocrea S; Pinto R; Thiemermann C
Med Sci Monit; 2002 Nov; 8(11):BR444-53. PubMed ID: 12444369
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.
Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S
Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366
[TBL] [Abstract][Full Text] [Related]
20. The effect of ischemic preconditioning prior to intraoperative radiotherapy on ischemic and on reperfused rat liver.
Hahn O; Szijártó A; Lotz G; Schaff Z; Vígváry Z; Váli L; Kupcsulik PK
J Surg Res; 2007 Sep; 142(1):32-44. PubMed ID: 17628599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
